Medicine guide
EMTRICITABINE/TENOFOVIR DISOPROXIL SANDOZ 200 mg/
As listed in the register: EMTRICITABINE/TENOFOVIR DISOPROXIL SANDOZ 200 mg/245 mg, comprimé pelliculé
245 mg + 200 mg · comprimé pelliculé
- Prescription only
- Active substance
- Ténofovir Disoproxil + Emtricitabine
- Made by
- SANDOZ
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | SANDOZ |
|---|---|
| Active substance | Ténofovir Disoproxil + Emtricitabine |
| Strength | 245 mg + 200 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure décentralisée |
| Name in the register | EMTRICITABINE/TENOFOVIR DISOPROXIL SANDOZ 200 mg/245 mg, comprimé pelliculé |
| Packs | plaquette(s) OPA : polyamide orienté aluminium PVC de 30 comprimé(s) · 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s) |
| CIS | 68486060 |
| CIP13 | 3400930111987 |
| CIP13 | 3400930111994 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).